LOGIN
BoNT-A injection within ECRB demonstrates efficacy versus placebo for lateral epicondylitis
June 2018
BoNT-A injection within ECRB demonstrates efficacy versus placebo for lateral epicondylitis
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A
Short-Term Effect of Low-Dose, Electromyography-Guided Botulinum Toxin A Injection in the Treatment of Chronic Lateral Epicondylar Tendinopathy: A Randomized, Double-Blinded Study
J Bone Joint Surg Am. 2018 May 16;100(10):818-826Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
60 patients with lateral epicondylitis were randomized to an injection into the extensor carpi radialis brevis (ECRB) of either botulinum toxin type A (BoNT-A) or placebo. Patients were assessed after 30 and 90 days. The primary outcome was the rate of patients who experienced a minimum 50% reduction in pain on a visual analog scale. Additional outcomes investigated included the rate of patients w...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.